The treatment of essential thromobocytosis revisited

To the editor: In “How I treat essential thrombocythemia,” Beer et al[1][1] unfortunately chose not to use all the evidence available to them. Essential thrombocytosis (ET) and its companion myeloproliferative disorders (MPDs), polycythemia vera (PV), and primary myelofibrosis (PMF) exhibit